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INTRODUCTION 
Glaucoma has always  been one of the leading cause of blindness 
in the developed countries. Changing trends have now been noted in 
developing countries like India . where glaucoma is the second leading 
cause of blindness . It was estimated that  the prevalence of  Glaucoma in 
India would  be 11.9 million by the year 2010 and 20% of the world 
glaucoma population  would be in India by the year  20201-3 . Clinical 
diagnosis of glaucoma is possible only after about 40% of the retinal 
ganglion cells are lost irreversibly. Though there is retinal ganglion cell 
loss as age advances in normal individuals, this progressive loss is 
hastened in patients with glaucoma. Since glaucoma causes an 
irreversible changes in the Optic Nerve head and the Retinal nerve fiber 
layer, prompt diagnosis is warranted4. If these RNFL and ONH changes 
were detected objectively earlier before the visual field loss has set in  
with a relatively new imaging technology like SD-OCT,  this progressive  
disease  can either be halted or slowed down by providing apt treatment 
and preventing the vision loss as the current modalities that are used are 
subjective and diagnose only later .According to the population based 
surveys, prompt diagnosis and treatment was given to less than  50% of 
patients with a documented visual field loss, which urges us for the use of 
a better diagnostic instrument.5-7 
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 In recent years Optical Coherence Tomography (OCT) has 
emanated as a cutting edge technology in imaging the eye providing  high 
resolution ocular images in 3 dimension. Optical Coherence Tomography 
(OCT) works under  the principle of low-coherence interferometryto 
determine  the echo time delay of the light reflected from various layers 
of retina is compared with the light reflected from the reference mirror 
used.This real time tomogram uses a very high axial resolution (3 to 15 
µm) for imaging the retinaand optic nerve head9-13. 
This dissertation aims to evaluate the retinal nerve fiber layer 
thickness and the optic nerve head changes in early to moderate glaucoma 
patients using spectral domain optical coherence tomography and 
compared them with age matched individuals.  
 
 
 
 
 
 
 
9 
 
REVIEW OF LITERATURE 
Spectral Domain Optical Coherence Tomography in 
Glaucoma: Qualitative and Quantitative Analysis of the Optic Nerve 
Head and Retinal Nerve Fiber Layer (An AOS Thesis) 
This study was done to analyze  the ONH and RNFL changes 
qualitatively and quantitatively using SD-OCT.SD-OCT was done on 
patients with  four stages of glaucoma, and they were compared with age 
matched individuals. They used two SD-OCT systems with one using 
titanium:sapphire as the light source and the other using Super-
luminiscent diode .They concluded that SD-OCT can detect the classic 
glaucomatous optic neuropathy and RNFL structural changes. The 
reference plane was kept at 139µ above the Retinal pigment Epithelial 
layer that correlated well with the subjective assessment. The minimum 
distance band best correlated with the subjective assessment. 
 
Comparison of Retinal Nerve Fiber Layer Thickness Measurements 
in Healthy Subjects Using Fourier and Time Domain Optical 
Coherence Tomograph 
The study was  conducted to analyze the RNFL parameters using 
two machines and to detect the reproducibility of Fourier domain 
measurement in normal individuals. They analyzed the average RNFL 
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thickness,quadrant wise and clockhour wise in the peripapillary area. 
They analyzed the repeatability the intraclass correlation co-efficient and 
co-efficient of variation in the RNFL parameters. They inferred that the 
Fourier domain  OCT had better reproducibility than stratus OCT. 
 
Comparison of Different Spectral Domain Optical Coherence 
Tomography Scanning Areas for Glaucoma Diagnosis 
This is a case-control study done to evaluate the RNFL, ONH and 
macular thickness in glaucoma patients using SD-OCT. They found that 
ROC for the inferior quadrant was the best among the RNFL as compared 
to the ONH  parameters. But no significant difference was  found 
between the ROC curve areas of macular thickness and RNFL  
parameters. They concluded that both RNFL and macular thickness 
parameters are good at detecting glaucoma than the ONH parameters. 
 
Detection of Early Glaucoma with Optical Coherence Tomography 
(StratusOCT) 
 The study was done to differentiate early glaucoma from the 
normal subjects using stratus OCT. The study included patients with early 
field defects, glaucoma suspects and age matched normal eyes. The study 
concluded that good sensitivity and specificity was found in patients with 
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early field defects. Among the glaucoma suspects, analyzed using stratus 
OCT, 50% were consistent with the subjective assessment. 
 
Retinal Nerve Fiber Layer Imaging with Spectral-Domain Optical 
Coherence Tomography Analysis of the Retinal Nerve Fiber Layer 
Map for Glaucoma Detection  
This was a prospective, cross-sectional study done to find if there 
is a difference in the RNFL thickness measurement done using 
conventional peripapillary RNFL measurement and the deviation map in 
SD-OCT. They concluded that the RNFL thickness deviation map is 
superior in identifying the nerve fiber layer damage as compared to the 
standard peripaillary RNFL measurement. 
 
Retinal Nerve Fiber Layer Measures in High- and Normal-Tension 
Glaucoma 
 This study was done to evaluate the RNFL defects in primary open 
angle glaucoma patients with high intraocular pressure and in patients 
with normal tension glaucoma using OCT. Regression analysis was done 
to correlate the parameters . They found that there was no significant 
difference in the RNFL defects among the high tension and normal 
tension glaucoma patients. 
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Structure–Function Relationships in Normal and Glaucomatous Eyes 
Determined by Time- and Spectral-Domain Optical Coherence 
Tomography 
This was a comparative study done to evaluate the relationship 
between retinal mean sensitivity  found using visual field perimetry and 
RNFL thickness measurement done using Time domain and Spectral 
domain OCT. They studied on glaucomatous eyes, glaucoma suspects 
and in normal subjects. The parameters were analyzed using linear and 
logarithimic regression analyses. They concluded that SDOCT is superior 
in detecting the structure function relationship as compared to Time 
domain OCT. 
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GLAUCOMA: 
Glaucoma is the most common cause of irreversible blindness 
worldwide. Population based studies have estimated, that the prevalence 
of glaucoma was 60.5 million worldwide by the year 20103 .The 
prevalence of Primary Open Angle Glaucoma (POAG) is estimated to be 
around 0.41–3.51%14-17,19-21. Prevalence surveys in Mongolia, Singapore, 
China and India have observed prevalence of both the primary angle 
closure and of open angle glaucoma to be same.  A greater proportion of 
people in Asia are bilaterally blind due to  angle closure glaucoma,  25 % 
of those  with PACG are blind as compared to 10% of those with POAG3. 
POAG is defined as a chronic progressive optic neuropathy with 
characteristic changes in the optic nerve head and visual field.  Heredity, 
high myopia, older age, race, family history (first-degree relative), thinner 
central corneal thickness and elevated intraocular ocular pressure (IOP) 
are the proposed risk factors for glaucoma 21 
 
GLAUCOMATOUS MORPHOLOGY OF THE OPTIC NERVE: 
The loss of retinal ganglion cells (RGCs) is found to be the basic 
pathology in the development of glaucoma, which results in characteristic 
optic nerve and visual field abnormalities. The nerve fiber layer is 
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composed primarily of retinal ganglion cell axons, neuroglia, and 
astrocytes22.The visual field changes can be detected  with Standard 
Automated Perimetry only after about 40% of the retinal nerve fibers are 
lost irreversibly.  So, structural changes are seen clinically after 
functional loss has occurred. Focal Retinal NFL defects may be an early 
sign of glaucoma, preceding optic disc and visual field changes23.The 
Retinal nerve fiber layer defects follows the normal anatomical pattern of 
the Nerve fiber layer in the retina. Normally, Fibres from nasal half of the 
retina come directly to the optic disc as superior and inferior radiating 
fibers and  is thickest in the superior and inferior poles, compared with 
the nasal and the temporal poles. There are many changes in the RNFL 
that are observed in glaucoma which includes a focal wedge-shaped 
defects, seen best with the red-free filter clinically or as a loss of the 
striated pattern  in RNFL 23 
.
These focal changes are best observed in the 
superior or the inferior areas of the nerve fibers as glaucoma tends to 
affect these fibers more often. 
Glaucoma can present with many progressive and asymmetric  disc  
changes. The neuroretinal rim begins to thin as the axons are degenerated. 
The focal degeneration of these retinal  ganglion cells  are observed as a 
focal thinning of the neuroretinal rim which is known as polar notching is 
the earliest sign of glaucoma. There is a selective loss of the inferior 
fibers earlier than the other quadrants, so this focal notching is observed 
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more often in the inferotemporal region of the ONH, followed by the 
focal notching in the superior region less frequently. So there is a vertical 
enlargement of the cup, which makes it clinically more significant than 
the horizontal enlargement. This is followed by the loss of fibers in the 
temporal quadrant and the nasal fibers are spared till the disease is in its 
advanced stages. Not more often, concentric enlargement of the cup is 
also observed as one of the early signs of glaucoma.  In few cases, the 
pores of the lamina cribrosa are exposed till the margin of the disc as  the 
cup deepens, which is known as LaminarDot sign, is seen in  
glaucomatous optic atrophy. There can also be a shallow cupping of the 
optic disc with retention of the central cup known as  saucerization 
extending upto the disc margin. Sloping is another early sign of 
glaucoma. Eventually all the neural rim tissues are lost leading to a total 
cupping  and the vessels  bending  at the margins of the disc known as 
bean-pot cupping. 
Vascular signs of glaucomatous optic atrophy include splinter 
hemorrhages, usually seen near the disc margin. Splinter haemorrhages 
are seen more often in patients with normal-tension glaucoma than in 
patients with Open angle glaucoma and glaucoma suspects with the 
incidence being 35.3% in normal-tension glaucoma, 10.3%in open angle 
glaucoma and 10.4%in glaucoma suspects24.  These splinter 
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haemorrhages were localized near the nerve fiber layer defect. The most 
common location for these hemorrhages is the inferior quadrant, but they 
may also be seen at any other point around the disc. They are rarely seen 
in advanced stages of glaucoma, but are more often seen in early to 
moderate stages of glaucoma25,26. The deepening of the cup can lead to 
overpassing vessels. The circumlinear vessels are bared along the margin 
of the cup known as baring of circumlinear vessls. Bayonetting of the 
vessel is the vessel that bends along the rim edge and there occurs 
nasalization of vessels.  
GLAUCOMATOUS VISUAL FIELD PROGRESSION: 
Visual field changes seen in early glaucoma can be generalized 
depression  and/or localized visual field defects. The early change  in the  
visual fields can be observed only in the periphery. Most of the times 
these early clues can be missed, as only 24 to 30 degree of central visual 
fields are checked  as time saving method .The visual field pattern  
fluctuates in these patients.As the inferior pole of ONH is involved  in 
early glaucoma, Isolated  visual field defects are observed in the superior 
half of the field. Very rarely the central fields may be affected early in 
glaucoma . In 41% of the patients27  the initial glaucomatous change that 
might be seen in the visual field is isolated paracentral scotoma. 
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 The visual field damage does not follow typical pattern always, it may 
manifest differently in different patients. As the disease progresses,retinal 
threshold increases gradually and uniformly along the field. Isolated 
defects can fuse and  further above and below the horizontal midline 
forming a Ronnes  nasal steps. Paracentral scotomas can coalesce to form  
arcuate scotomas.Arcuate scotomas above and below the midline forms 
the double arcuate scotoma  . New defects can also appear with further 
progression. The central and temporal islands  are spared till the end stage  
glaucoma leading to tubular vision . With further damage ,these fields are 
lost , central being lost earlier than the temporal field. In the end stage 
disease,all the nerve fibres ar lost leaving the patient blind. 
 
NATURAL HISTORY OF OPEN ANGLE GLAUCOMA : 
The word  glaucoma is  derived from the Greek word glaucosis, 
which means  clouded or blue-green hue. This probably was used to 
describe the decompensated edematous cornea or the cataract which 
develops as a sequelae to the raised intraocular pressure  . POAG is the 
most dreadful blinding disease, as being symptomless in the initial stages 
with just peripheral field loss, patient does not seek  any health care , 
delaying the diagnosis . By the time the patient  becomes symptomatic 
and approaches the clinician irreparable damage has already occurred to 
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the  visual fields.  The disease  progression differs  in each  patient, and 
each patient respond differently to the treatment,though aimed at 
preserving  the remnant field, may not be fruitful despite aggressive 
therapy28,29. 
A Study conducted in white population by Hattenhauer et.al. has 
estimated that approximately 9% patients may go blind in bothe eyes 
after 20 years30 .Population based studies have found that the mean 
deviation in visual field testing varies for various ethnic groups,though 
they were not statistically significant.31 
The Landmark study,The Ocular Hypertension Treatment Study 
was done basically to identify the percentage of conversion to Open angle 
glaucoma from ocular hypertension. The study also tried to find if the 
incidence of developing open angle glaucoma can be reduced by reducing 
the intraocular pressure. The cases were followed for 60 months, and the 
inference was that 9.5% of the untreated group developed glaucoma 
whereas it was reduced to 4.4% in the treated group. So, the reduction of 
intraocular pressure had a beneficial effect in 54% of the study group. But 
no glaucomatous changes were observed in the optic nerve head or the 
visual field in 90% of the control population. So if the patient does not 
have any known risk factors like high myopia, thin corneas, increased 
vertical cup to disc ratio, high intraocular pressure, old age and increased 
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pattern standard deviation on the visual field then they can just be 
observed and kept on a regular followup.32,33 
The visual loss due to glaucoma can be predicted from the 
pathogenesis of Open Angle glaucoma that has been elucidated from the 
data available in the no treatment group of Randomized Early Manifest 
Glaucoma Trial (EMGT). At 4 years, nearly 50% of the individuals who 
didn’t receive treatment have shown progression compared with 30% of 
the individuals who received treatment with the average Intra-Ocular 
Pressure (IOP) lowering seen at 25% in the later 34, 35. More than 60% of 
the untreated individuals at 6 years follow up have showed distinct 
progression in the visual loss with the overall median time being 42.8 
months. This study has also shown that each individual had varied 
progression of the disease. Some had a rapid progression, with MD Index 
more than 10dB per year while others had a minimal or no progress at all 
even when they were followed up for a long time. The progression is seen 
in more than two-third of individuals with Intra Ocular Pressure ≥ 21 mm 
Hg i.e. High Tension Glaucoma group with a median time at 44.8 months 
while only just over 50% in NTG showed progression with a median time 
at 61.1 months. The percentage of progression in Pseudoexfoliation 
patients (PXEG) is more than 93% with median time at 19.5 months. 
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Though some individuals showed rapid progression majority of these 
patients progressed slowly36.  
This variation in the disease progression is also similar to the 
findings of Collaborative Normal Tension Glaucoma Study (CNTGS). 
EMGT and CNTGS have similar documentation of the disease 
progression of untreated NTG 37. The main focus of this study is on visual 
field loss  and the optic neuropathy in glaucoma with normal range of 
Intra Ocular Pressure. 
After a follow up of 5-7 years, 60 % progressive visual field defect 
is seen in untreated individuals with glaucomatous optic neuropathy and 
IOP less than 21 mm Hg. Intervention targeting individuals with IOP 
lowering of > 30% has lowered the rate of progression by 20% 37. 
The manifestation of the disease varies to extremes. Slow 
progression is seen in some taking several years to manifest itself while 
some manifested the deterioration within 1 year. 
The untreated subjects had their mean slope of MD index 
deterioration at - 0.41dB/year with index ranging from -0.2dB/year to -
2dB or more/year. This only represents the wide range in the rates of 
deterioration. 
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This high variation warrants in identifying factors that can aid in 
clinical diagnosis, monitoring of progression and intervention at 
appropriate time.  
In the EMGT, when comparing the clinical course of the disease of 
younger individuals with individuals older than 68 years of age, the later 
manifested the disease faster. Prediction of this early manifestation and 
progression can be done with the help of factors like frequent disc 
hemorrhages, both eyes with glaucoma and larger field defects at initial 
diagnosis as measured by perimetric MD. In individuals with PXEG 
glaucoma is more aggressive disease than NTG and HTG wherein the 
mean for attaining full field blindness is within 10 years. 
Intra Ocular Pressure also yields in faster progression of the 
disease. Individuals with IOP > 21 are more likely to progress faster than 
those with IOP < 2138.   
While the risk of rapid development of blindness is very low in 
NTG, this risk is high in patients with HTG and PXEG, thus the 
aggressiveness of the therapy varies according the groups. But keeping in 
mind the high variation within the groups the treatment is tailored to each 
individual based on their clinical presentation and interpretation. 
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It is evident from the two prospective studies EMGT and CNTG 
that involves the individuals with glaucoma who are not treated that 
clinical course of the disease and its progression varies widely and every 
individual should be monitored carefully with tailored line of treatment. 
 
HISTORY OF OPTICAL COHERENCE TOMOGRAPHY 
The first retinal imaging was performed in 1989 by David Huang. 
The first prototype ophthalmic OCT was placed at the New England Eye 
Center in 1994.  In 2002 ,OCT 3 (Stratus OCT), became commercially 
available which was then considered the “gold standard” for retinal 
imaging till the advent of Fourier domain OCT or SD-OCT, or hsHR-
OCT came into picture in 200622 
In 1991, Huang and his coworkers39  first demonstrated using a  
prototype OCT with 15-µm axial resolution in Science ,its role   in  
imaging  a human retina. They were able to compare OCT images with 
histology of the retina. In 1993, Fercher and associates40 were successful 
in presenting  the first in vivo OCT images, and  in 1995 it was  Huang 
and his coworkers  again  who produced the first images of retinal 
disease41,42. Retinal images  were presented using an  OCT  with 
improved  axial resolution of  10 µm. The prototype instrument was a  
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modification of slit-lamp biomicroscope and would enable simultaneous 
OCT imaging. Using this system, they demonstrated imaging of both the 
foveal contour and optic nerve head in vivo22. 
The spatial location of reflected light was determined by the light 
wavelengths instead of echo time delay which was the milestone in the 
evolution of OCT. Using Fourier transformation, the OCT has evolved 
from TD-OCT to SD-OCT. The TD-OCT used theposition of a moving 
reference mirror  which was used to encode the location of each reflection 
in the time information,39,40 whereas SD-OCT, which has a stationary 
reference mirror, gives the required  information using a spectrometer.  
By this way, we get more information, increase in the number of scans 
within a short duration, making SD-OCT, a very useful too clinically for 
both the anterior and the posterior segment11,42,43,44 
In 2001, Wojtkowski and colleagues presented the first in vivo SD-
OCT scans and gave the technical details of the method. The data capture 
was rapid, however as the processing of images  took 30 minutes to 
obtain,the clinical use of this technology was impractical at that period of 
time. The SD-OCT ophthalmic scans were 45 had a dramatic improvement 
with this technology in which   each 500×500-pixel image could be 
processed in   only 20 seconds. US Food and Drug Administration (FDA)  
has approved to use  SD-OCT devices for clinical purposes, for  its much 
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faster acquisition speed, 3D data that can be acquired and a good 
resolution of the structures.Faster machines are used for the Research 
purposeswith  better axial resolution are now available  though not used 
clinically14 . 
Besides observing the structural anatomy of retina and other 
tissues, role of OCT has  now been extended to monitor  the physiological 
and pathological function of tissue characteristics. Doppler OCT methods 
similar to Doppler ultrasound  are being  used  in Retinal blood flow 
studies which are in  their initial stages, to look at flow both 
quantitatively and qualitatively45-48 .Assessment of  blood oxygenation in 
retinal arteries and vein was done by  Kagemann and colleagues using the 
spectral data of SD-OCT49. The role of OCT to study the retinal functions  
was emphasized  by three  published studies demonstrating 
“optophysiology,” in which following exposure of light to retina , OCT 
analyzed the layers of the retina in vivo50-52. 
Optical coherence tomography technology has evolved 
substantially over a relatively short span of time, from Time Domain to 
the Spectral Domain OCT, which takes much less time that allow 
researchers to identify properties of the retinal tissue beyond structure. 
This shows the rapid evolution of the OCT which is becoming an 
inevitable tool in the field of Ophthalmology22 . 
Figure:  Schematics of spectral domain optical coherence 
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OCT TECHNIQUES: 
Spectral Domain OCT uses similar hardware as Time Domain 
OCT with a few modifications.  The basic principles of OCT and 
ultrasound are similar with exception ofOCT using light as its medium 
while ultrasound uses sound.  The SD OCT uses spectrometer to analyze 
the reflected light. The above methods results in a creation of three 
dimensional images based on measuring the echo time delay and intensity 
of reflection and back scattered light or sound. The A scan is the  image 
of the variations in  the optical reflectance through the depth of the tissue  
depicted along a point  by the OCT   whereas  B-scan is the cross 
sectional image of these single axial scans through the tissue which are 
gathered linearly across the tissue. 3D data set is then constructed based 
on the collection of parallel B-scans. Summing all the pixels in each 
given scan A and presenting to 3D data cube produces an OCT fundus 
image57-59.  
Advantage of using OCT fundus image is that it has actual OCT 
topographic data but the SLO or fundus photograph has an upper edge in 
faster acquisition and minimal movement artifact. The difference in the 
medium makes OCT have much higher axial resolution compared to 
ultrasound.  Time domain OCT uses an axial resolution of 10 µm [9,13,53]  
whereas  for an spectral domain OCT it is 5 to 7 µm . Ultrasound uses an 
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axial resolution of 150 µm at a frequency of 10 MHz.  With higher 
frequencies of ultrasound, higher axial resolutions can be achieved. 
Anterior segment OCT uses an ultrasound frequency of approximately 60  
MHz and axial resolution of approximately 40 to 20 µm and poor depth 
of penetration 4 to 3 mm.  Light being the medium in OCT has the 
advantage of non-contact while ultrasound requires a medium like water 
to pass the sound waves between transmitter and tissue. Hence,  
ultrasound is more useful in detecting the  axial length and the anterior 
segment, whereas OCT is more useful technique to detect in detail the 
structures in the retina and anterior segment. Though OCT and ultrasound 
creates images using principles of reflection, the methods for detecting 
these reflections is however different for both. The speed of light being 
much faster thansound, the time delay in reflections from different layers 
being in the order of femtosecconds cannot be measured directly. Hence 
the principle of low-coherence interferometry is used in OCT to measure 
the delay in time corresponding to distances between structures. A laser 
with broad bandwidth or a source of super luminescent diode source  is 
used and the beam travels to a beam splitter. This beam is split into two, 
one goes to a mirror at a known position on a reference arm while the 
other to sample arm and gets scattered and reflected from the tissue 
structure. The light beams from reference and sample arms travels back to 
the beam splitter and recombines forming a constructive interference 
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pattern. This pattern is then sensed by a photodetector. The resolution of 
the interferometer is defined by the width of the signal envelope and is 
based on the coherence length of the light used. The coherence length is 
in turn dependent on the bandwidth, the broader the bandwidth, the lower 
the coherence light. Finer resolution can be obtained when the light of 
shorter coherence wavelength is used22. 
         In TDOCT, the reference mirror is placed at a known distance and 
the position is altered for each axial scan to allow imaging of the depths 
of the tissue. Each pixel in the A-scan presents the  reflection intensity at 
that position. This reflection intensity is converted to a log scale because 
it varies widely up to 45-dB approximately. Initially, the OCT system 
was based on the principle of Michelson interferometer 22. TD-OCT uses 
a fiber-optics system. SD-OCT and TD-OCT has similar principle; 
however, the signal acquisition is better in SD-OCT as compared to TD-
OCT. The TD-OCT has a moving reference mirror, whereas it is kept 
stationary in SD-OCT. The interference pattern in SD-OCT is split by a 
grating into its frequency components, simultaneously these components 
are then detected by the charged-couple device(CCD). This device has 
group of arranged photodetectors, each photodetectors individually 
responds only to a specific frequency range12,42-44. These frequencies 
specifically correspond to certain depth within the tissue after Fourier 
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transform of received signal allowing simultaneous gathering of all points 
along each A scan and thus increasing the scan speed. Like TD-OCT, B 
scan be obtained by using A scan along the transverse plane. SD-OCT is 
also called as Fourier domain OCT because of encoding of distances in 
the Fourier transform of the frequencies of light reflected. The advantage 
of SD OCT over TD OCT is  that it takes 40,000 axial scans per second 
as against TD OCT which takes only 400 axial scan per Second. The 
speed restriction of TD OCT is because it uses a moving reference mirror 
calculate the time taken by the light to be reflected
 
42
. The beam waist 
size defines the Transverse resolution  54 
 
fundamentally by projecting the 
beam as well as any aberrations in the eye. Scan density which is 
dependent on A-scan sampling rate is sometimes incorrectly interpreted 
as transverse resolution6,34,35,55 .The resolution of TD OCT depends on the 
number of A scan that were taken. Arbitrarily the scan time increases 
with increase in the number of A scan taken. The transverse resolution is 
higher with better scan density in a long duration scan but is highly 
susceptible to artifacts created due to movement of eyes . The chances of 
motion artifacts  is reduced with shorter-duration scans. As said earlier  
SD-OCT devices are  approximately 100 times  faster than the 
conventional  TD-OCT. 39,40,53,55.3D data can be constructed based on 
these  set of Bscans acquired on a faster rate. With the faster speed of the 
scan , images can be improved with lesser artifacts . 3 D  images  can be 
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further worked upon and processed  for better visualization  and to 
acquire   further quantitative and qualitative datas . Graphically these    
images can be displayed  as either grayscale or false color images. With 
Grayscale there is better interpretation and smaller details can be picked 
up easily. As it is easier for the human eye to differentiate multiple colors 
rather than various shades of gray, use of false color imaging in OCT 
makes it easier to identify the tissue structures. But this carries the 
disadvantages of inducing artifacts. False color imagingshows highly 
reflective structures in bright colors like red and white  with the intensity 
as high as ~ - 50dB while darker colors like blue and black represent low 
reflectivity structures with intensity as low as ~ -95dB and green 
represents intermediate reflectivity. 
           OCT datas can often be compared to histological sections. To find 
out the pathology and  identify the inter visit varibilities observed to 
detect any progression, automated segmentation techniques are important. 
Segmentation is  possible using SD-OCT through which we can analyze 
and determine the inner retinal complex which includes  RNFL, retinal 
ganglion cell layer (RGCL), and inner plexiform layer. Three steps are 
involved in segmentation which includes smoothing, edge detection, and 
error correction. OCT has a normative database in its printouts so  makes 
it easier for the clinicians to interpret the datas of the patients and to 
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correlate whether the data is normal or outside normal limits. So 
segmentation is vital in glaucoma. Segmentation helps in the quantitative 
analysis of the RNFL thickness, in this the  highly reflective layers appear 
in hot colors like red. Since RNFL thinning is noticed in the pre-clinical 
stage of glaucoma, before any field defect would appear, measuring the 
RNFL thickness is very important41,60. So, analyzing the RNFL quadrant 
wise and clock hour wise may give a more valuable information than just 
measuring the average thickness. Schuman and colleagues 61 defined the 
3.4-mm circumpapillary RNFL thickness scan as the standard for TD-
OCT glaucoma assessment in the  earlier periods. 
OCT IN GLAUCOMA : 
Since the diagnosis of glaucoma in its early stages may be very 
critical and is more subjective, we need an objective method to diagnose  
glaucoma. Optical Coherence Tomography is a robust technology in 
glaucoma providing objective, high resolution images . The clinical signs 
of glaucoma include polar notching, more often seen in the inferior and 
superior poles of the optic nerve head, disc haemorrhages, asymmetric 
cupping of more than 0.2 between the two eyes, asymmetric appearance 
of the neuroretinal rim.62,63  The diagnosis of Glaucoma is made when 
there is a loss of neural rim with its corresponding visual field defects64. 
The visual field defects observed in glaucoma are generalized depression, 
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paracentral scotoma, arcuate scotoma, nasal step of Ronne, a double 
arcuate scotoma, as the disease progresses can result in a temporal or a 
central island of vision65. The proposed  risk factors of glaucoma include 
high intraocular pressure (IOP), thin corneas, heredity, old age, high 
myopia, diabetes, hypertension and cardiovascular disease66-68 .   Loss of 
retinal ganglion  cells is the finding in glaucoma69-70 leading to exposure 
of the lamina cribrosa  and is often associated with transsynaptic 
degeneration in the lateral geniculate nucleus and beyond as well71-75. 
TD-OCTused a 3.4mm circumpapillary scans to image the RNFL76-80. 
The  retinal segmentation helps us to  analyse the course of the  
disease  and its progression  by comparing the  Retinal nerve fiber layer 
thickness in glaucomatous eyes with the  normative data base .[80]Intertest 
reproducibility was less for average RNFL thickness and can be improved 
in a well dilated pupil.[78,81]Better imaging with finer details of the retinal 
layers and the nerve fiber layer thickness can be obtained with Fourier 
domain OCT (~2 to 3 µm) due to its high resolution than the conventional 
TD-OCT that increases the reliability of the test. The scan quality should 
be good to get a reliable Segmentation algorithms 82,83
.
The newer 
softwares in SD OCT has helped better detection and progression analysis 
in glaucoma .Commercially available OCT’s like  the  Cirrus HD-OCT 
has improved software packages like Ganglion Cell Analysis  and Optic 
33 
 
Nerve Head Progression Analysis for glaucoma . It also includes the 
Guided Progression Analysis which detects the RNFL changes over time, 
it creates a report, where  the average RNFL thickness based  on  4 visits  
is analysed in a linear regression pattern against the follow up  duration 
and this change is expressed in µm/year . The Spectralis OCT has 
softwares to  reduce motion artifacts  and improve repeatability results 
like the TruTrak  and Noise Reduction OCT signal and newer software 
like Posterior Pole Asymmetry Analysis which plots asymmetry in the 
RNFL thickness along the posterior pole across the horizontal hemisphere 
and between the two eyes .3D data sets can be created with newer OCT’s 
like  3D OCT-1000 (Topcon )  and   Cirrus HD OCT . Since the OCT 
scans a larger area and in depth we get better information about the  
retinal ganglion cell defects. Functional data in glaucoma can obtained 
using  SD-OCT to measure physiological parameters like the retinal 
blood flow in glaucoma and the oxygenation which is still in its research 
stage45-49.The pathology of glaucoma can be assessed by Optophysiology  
for functional assessment of glaucoma.51,52,84 
OPTIC NERVE HEAD IMAGING: 
Spectral domain optical coherence tomography, a relatively new a 
imaging modality which can be said as a boon to the posterior segment  
ophthalmic surgeons as it gives a three dimensional structure of the 
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ONH85,86, through which we can now acquire a 3D-isotropic image of the 
structures to be studied. Isotropic means that the size of each imaged 
element, or voxel, is the same in all three dimensions121. With the advent 
of this isotropic imaging technology, we can get almost an accurate 
measurement of the optic nerve head. So this is a very useful technology 
which takes us one step higher in the treatment and follow up of the 
patients with glaucoma. However, as a  routine glaucoma management 
was based on the clinical findings like IOP measurement, ONH imaging 
and the visual field parameters. Due to the narrow band width in SD-
OCT, the clinical findings like the properties of the disc like the colour 
changes are missed in SD-OCT121. 
       Though SD-OCT provides a detailed information about the ONH 
parameters, we are not able to assess which of these parameters are more 
useful in detecting the progression of glaucoma. Since glaucoma is a 
disease of chronic optic neuropathy, the disease undergoes changes over 
many years121. However, the datas provided by SD-OCT may be useful in 
the evaluation and interpretation. Hence, as elucidated by Burgoyne et al, 
SD-OCT may be used to evaluate the progression of glaucoma88-90 .  
Cirrus system software could detect the changes  in  the optic nerve 
head margins.. Kim et al used two methods  to detect optic nerve head 
margins  which are centred each time method  and centred once method , 
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and found no difference in the datas . Gabriele et al analyzed no 
significant difference with the RNFL measurements  than the ONH 
measurements 91. The present result of 58 µm ONH centre location 
deviation is well within this stability margin.  
 
RNFL THICKNESS MEASUREMENT IN GLAUCOMA : 
Clinically RNFL defect can be detected using a red-free 
photograph qualitatively, the quantitative assessment can be done using 
the two imaging technology– OCT and scanning laser polarimetry. RNFL 
is highly reflective on an OCT. The various RNFL thickness 
measurement analysis protocol includes RNFL thickness circle scan, fast 
circle scan, concentric three ring protocol, RNFL map and proportional 
circles. Circular scan of 1.34 mm radius centered on the ONH  exhibit 
maximum reproducibility  for RNFL measurement . 
The measurement of RNFL thickness is determined by the difference in 
distance between the vitreoretinal interface and a posterior boundary, 
based on a predefined reflectivity signal level. In SLP the RNFL 
thickness  is measured based on its birefringence property . 
With the advent of SD-OCT, the RNFL thickness measurement 
reproducibility has considerably improved as quoted by many studies.  It 
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gives a statistically significant datas as compared to the conventional TD-
OCT. This could be because SD-OCT provides the data in 3 dimension 
and reduces the motion artifact due to the  faster imaging technology.  
Moreover  SD-OCT with its high axial resolution can define RNFL 
boundaries more accurately, which makes it a more powerful tool as 
compared to the TD-OCT.122 
THE  NEED FOR IMPROVED IMAGING IN GLAUCOMA :  
Better  objective screening methods is needed  to diagnose 
glaucoma early in a population hugely affected by this disease . As the 
damage caused is irrepairable, early diagnosis and prompt treatment  is 
warranted . Treatment is aimed at halting the progression and preserving 
the residual vision . Diagnosis is usually delayed till the advanced stages 
as in the earlier stages patient is symptomless  till  prominent central 
fields are preserved 22. Diagnostic modalities used till present date like 
the visual field is subjective based on patients response and the clinicians 
interpretation of the result . These modalities can detect glaucomatous 
damage only after significant nerve tissue lost ( ~40% or beyond) .92-95 
present modifications in the diagnostic methods like the scanning laser 
polarimetry, confocal scanning laser ophthalmoscopy, and time domain 
optical coherence tomography (OCT)  helps in early and objective  
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assessment of  the the optic nerve head (ONH) and the retinal nerve fiber 
layer (RNFL) changes in glaucoma . 
These methods have reported  structural changes that can be seen 
before the clinical changes. Rnfl changes are seen to be more sensitive 
than ONH parameters on OCT .96 thinning of RNFL seen in glaucoma 
correlates with the ganglion cell loss indicating glaucomatous pathology 
.
97
 RNFL loss seen in red free photographs can be detected 6 years before 
the clinical manifestation .98 Interestingly, Deleon-Ortega et al. has 
quoted that the current modalities that are used to diagnose glaucoma are 
better in ONH imaging as compared to RNFL imaging.99 The Ocular 
Hypertension Treatment Study (OHTS) concluded that the 
ophthalmologist can diagnose glaucoma based on the serial fundus 
photographs taken over  5 years time before they developed any field 
defect. 100  So the early diagnosis is very important to provide apt 
treatment, but according to the surveys conducted very few patients were 
diagnosed early and received prompt treatment 6,7,100. 
Longitudinal follow up of  glaucoma is essential in detecting the 
rate of progression of the disease, as glaucoma is a slowly progressing 
disease. 101Approppriate treatment can be offered and the vision can be 
restored if we had a better imaging modality. 
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WHY COMPARE WITH AGE MATCHED INDIVIDUALS?  
To evaluate the Retinal nerve fiber layer thickness, the disc area, 
age of the patient and the neuroretinal rim should be considered, because 
it was found that the nerve fiber layer thickness increases with an increase 
in NRA. As age advances the retinal nerve fiber layer thickness 
decreases. Patients with large disc had a thick peripapillary retinal nerve 
fiber layer as compared to patients with a normal disc size. 
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AIMS  AND  OBJECTIVES 
    
PURPOSE 
To assess the peripapillary retinalnerve fiber layer (RNFL) 
thickness and optic  nerve head (ONH) parameters measured with 
SD-OCT in glaucomatous eyes. 
 
AIM 
• To evaluate the  efficacy of spectral domain OCT in detecting  the 
glaucomatous ONH and RNFL changes in patients  with early to 
moderate glaucoma 
• To compare the retinal nerve fiber layer thickness and ONH 
changes  in early to moderate glaucoma with their age matched 
individuals using SD OCT  
 
 
 
 
 
 
 
40 
 
MATERIALS  AND  METHODOLOGY  
 
An observational prospective case control study to evaluate the 
retinal nerve fiber layer thickness and the optic nerve head changes in 
early to moderate glaucoma patients and compare them with age matched 
controls using spectral domain optical coherence tomography. The study 
was undertaken in the Department of Glaucoma Services, Aravind Eye 
Hospitals, Madurai. The study was conducted from  Oct 2010 to Mar 
2012. 
 
SUBJECTS 
INCLUSION  CRITERIA 
• Diagnosed cases of Primary open angle glaucoma. 
• Age 18 to 70 years. 
• Early to moderate glaucoma on disc evaluation. 
 
EXCLUSION  CRITERIA 
• Secondary glaucoma 
• Angle closure glaucoma 
• Advanced glaucoma 
• Media opacities like significant cataract, corneal opacity etc 
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• Congenital  Developmental glaucoma 
• Refractive error > - 6.0D < +3.0 D Sph.   
• Astigmatism  > 3.0D  
• congenital anomaly of the anterior chamber  
• concurrent active eye disease in the study eye that may affect 
intraocular pressure  
• Eyes with proliferative or severe nonproliferative retinopathy  
•  Eyes with field loss attributed to a nonglaucoma condition 
• Eyes with dilated pupil diameter of less than 3 mm.  
The study participants include 59 patients diagnosed with Primary 
open angle glaucoma in the case group and  51 normal patients attending 
the out patient department for a routine checkup taken as controls.  
All the study participants including both the cases and the control 
group underwent  the following investigations: 
• BCVA using Snellen’s chart 
• Slit lamp biomicroscopy  
• Gonioscopy  
• Perimetry (Humphrey visual field Analyzer ,central 24-2 test, size 
III   ,white stimulus, SITA-standard strategy).  
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• IOP measurement using Goldmann Applanation Tonometry  
• Central Corneal Thickness measurement 
• Spectral domain OCT 
• Dilated Fundus examination using 90D lens 
• Informed consent 
Glaucomatous appearance of the optic disc defined by the presence 
of neuroretinal rim thinning, disc haemorrhage, notching, 
excavation, presence of RNFL defect seen with red free image or 
asymmetry of the vertical cup to disc ratio of greater than 0.2 
between the two eyes.Glaucomatous eyes were classified as early 
to moderate glaucoma  on the basis of the following classification.  
 
GRADING OF GLAUCOMATOUS DAMAGE122 : 
Mild damage(grade 1) is characterized by minimal cupping, a nasal 
step or paracentral scotomas and a MD <-6dB. 
Moderate damage (grade 2) is characterized by thinning of the 
neuroretinal rim, an arcuate scotoma and a MD <-12dB. 
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Severe damage (grade 3) is characterized by marked cupping, 
extensive visual field loss including defects within the central 5 degree 
and a MD >12dB. 
 
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY 
CIRRUS TM HD -OCT 
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Figure – A patient getting Spectral domain optical coherence 
tomography done 
 
 
 
 
 
45 
 
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY:  
The study was conducted Using Cirrus™ HD-OCT software for 
analysis. Cirrus HD-OCT provides qualitative and quantitative data both  
in 2D and 3D . The wavelength of the light used is 840nm and can 
acquire27,000 A-scans per second and about 200-512 B-scans per 
second, and constructs a 3D retinal map by aligning the B-scans. The 
Cirrus™ HD-OCT of the optic disc scans 6x6 mm cube which is formed 
from 200 A scans  for each of 200 B scans. The machine detects 
segmentation of this 6x6 mm area and analyses the 3.46mm circle around 
the optic disc area. The RNFL thickness around this peripapillary area  
analyzed is compared to the normative database. This normative database 
is available for patients over 18 years of age. This normative database is 
color coded. 90 % of normal population will fall below the green zone, 
5% or less will fall below the yellow zone and 1% falls below the red 
line. The signal strength is mentioned from 0 to 10. 10 is the maximum 
limit, values below 6 are considered poor quality. The RNFL  thickness 
maps are also color coded which is studied in the 6x6 mm cube. Thicker 
RNFL areas represented by the warm colors and the thinner areas by the 
cool colors. The optic disc is excluded which is displayed in dark blue. 
The color code expresses the thickness from 0 in blue color to 350 µ in 
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white color. The deviation map compares the patients values with the 
normative data. 
Statistical Methods  
The Statistical analysis was performed by STATA 11.1 (Stata corp 
college station TX USA). The continuous variables were described by 
mean, Standard deviation, median and interquartile range. And the 
categorical variables were described as frequency and percentage.  
Student’s Independent sample t-test or Mann Whitney test was used to 
analyze the age, ONH parameters and RNFL thickness parameters 
compared with POAG and controls groups. Receiver operating 
characteristic (ROC) curves were used to describe the ability to 
discriminate glaucomatous from healthy eyes for each RTVue values 
software-provided parameter. The ROC curve provides the trade-off 
between the sensitivity and 1 -specificity. An area under the ROC curve 
(AUC) of 1.0 represents perfect discrimination, whereas an area of 0.5 
represents chance discrimination. Sensitivities at fixed specificities of 
80% and 95% were determined for all the parameters. 
 
 
 
 
 
OBSERVATION
 
Table 1  : Case and Control
 
Cases
Control
Total 
 
Graph 2: Percentage of Cases
The study included 118 eyes of 59 patients diagnosed with Primary 
open angle glaucoma and 102 eyes of 51 patients taken as controls. 
(Table 1 )  
 
Control
n=51 (47%)
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 & RESULTS  
 
Eye No. Of 
Patients 
 118 59 
 102 51 
220 110 
 
Cases
n= 59 (53%)
 
Table 2 : Demographics 
 Case
Male 39 (57%)
Female 29(43%)
Age (yrs) 54.13 ±  11.9
Graph 2:  Gender Distribution
The gender ratio was 39(57%) males and 20(
29(52%) males and 22(48
mean age of 54.13 ±11.9   was age matched with the control group in 
which the mean age of the patients was 53.54±7.3.  ( 
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 Control P-Value 
 29(52%)  
0.320 
 22(48%) 
 53.54  ±  7.37 0.565 
 
 
43%) females in cases and 
%) females in controls. The case group with the 
 Table 2  ) 
Control
52
43
48
Male Female
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Table 3  : Visual field variables  
 Cases Control  
 Median  (  1st& 3rd 
Quartile) 
Median  ( 1st& 3rd 
Quartile) 
P-Value 
MD(dB) -7.82    (-10.7 , -4.57) -2.175  ( -2.98,-1.39 ) <0.001 
PSD(dB) 5.565   ( 2.99, 8.18  ) 2.47 ( 1.95 ,3.31) <0.001 
 
The visual field parameters analyzed were mean deviation and 
pattern standard deviation. The median of mean deviation  in the case 
group  was  -7.82 and  that of Pattern standard deviation was 5.565. The  
median in the control group for mean deviation was  -2.175 and that of 
Pattern Standard deviation was 2.47.  Significant differences were found 
for the parameters in the two groups (p<0.001).  (Table 3 ) 
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Table 4   :   ONH Parameters 
 Cases Control P-Value 
C D Ratio 0.76 ± 0.07 0.48 ± 0.11 <0.001 
VCD Ratio 0.74 ± 0.08 0.48 ± 0.09 <0.001 
Rim area(mm2) 0.89  ± 
0.25 
1.21 ± 0.28 <0.001 
Disc Area (mm2) 2.07 ± 0.50 2.28 ± 0.43 0.001 
Cup Volume (mm3) 0.59±0.31 0.33±0.16 <0.001 
 
The mean values of the Optic Nerve Head parameters in the two 
groups are shown in Table 4.Significant differences were observed 
between the two groups for all the parameters.   
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Table 4a:  ONH parameters : AUC and sensitivities at fixed 
specificity 
 Sensitivity at 
95% 
Specificity 
Sensitivity at 
80% 
Specificity 
AUC 95 %. C.I 
Vertical CD 
Ratio 
91.53 98.31 0.98  0.96 – 0.99 
Cup Volume 35.59 78.81 0.83 0.77 – 0.89 
Disc Area 4.0 25 0.65 0.57 – 0.72 
Rim Area 39.0 65 0.82 0.76 – 0.87 
 
All ONH parameters showed significant area under the curve (AUC) 
values in the ROC curve analysis . The best parameters from the optic 
nerve head analysis were the vertical Cup to Disc Ratio (AUC 0.98), the 
cup volume (0.83) and  the rim area  (AUC 0.82) , least AUC value  was 
observed for the disc area  (AUC 0.65)  The parameter with the greatest  
sensitivity at 80 % specificity was the vertical Cup to Disc Ratio 
(98.31%)  followed by cup volume (78.81 %)  .  (Table 4 a ). 
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     Graph  1 : Vertical CD Ratio       Graph  2 :    Cup Volume 
 
 
 
 
      Graph 3 :   Disc Area      Graph  4 :      Rim Area 
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The mean average Retinal thickness for the case group  was 
76.84±11.29 and for the control group was  91.76±10.69, the difference 
between the two group was  statistically significant ( p < 0.001) .In the 
case group ,the average thickness in inferior quadrant  was 90.69 ± 23.9, 
94.19 ± 17.96 in superior, 63.68 ± 14.81 in nasal , 60.66 ± 12.91 in 
temporal quadrant , as compared to the control group which was 118.44 ± 
14.89 in the inferior  , 116.78 ± 14.35 in superior  , 74.30 ± 13.91 in nasal  
and  71.54 ± 13.98 in temporal quadrant respectively.(Table 5) 
All RNFL parameters showed statistically significant reductions in 
RNFL thickness in the case group as compared with the control group. 
The parameter with the largest AUC among the RNFL thickness 
parameters was the average RNFL thickness  (0.87). The temporal ( 0.72)  
and nasal  quadrants (0.69) showed lower AUC values as compared to the 
superior(0.84) and inferior quadrants(0.83)  . The parameter with the 
greatest  sensitivity at 80 % specificity were the average RNFL thickness 
(74 % ) and  RNFL thickness in inferior quadrant (74%) . 
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Table   5 : RNFL  parameters in microns 
 Cases Control P-Value 
Inferior 90.69 ± 23.9 118.44 ± 14.89 <0.001 
Superior 94.19 ± 17.96 116.78 ± 14.35 <0.001 
Nasal 63.68 ± 14.81 74.30 ± 13.91 <0.001 
Temporal 60.66 ± 12.91 71.54 ± 13.98 <0.001 
Mean Average 
Thickness 
76.84 ± 11.29 91.76 ± 10.69 <0.001 
 
Table  6 RNFL Thickness parameters -  AUC   and sensitivities at fixed 
specificity 
 
 Sensitivity  
(%) at 95% 
Specificity 
Sensitivity 
(%) at 80% 
Specificity 
AUC 95 %. C.I 
Superior 38 71 0.84 0.79 – 0.89 
Inferior 25 74 0.83 0.78 – 0.89 
Nasal 7 43 0.69 0.63 – 0.77 
Temporal 21 54 0.72 0.65 – 0.79 
Average 50 74 0.87 0.82 – 0.91 
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Graph  5 :AUC for         Graph 6 :AUC 
         Superior quadrant                               for   inferior  quadrant 
 
 
 
 
 
Graph 7  : AUC for Nasal            Graph 8 : AUC for temporal 
quadrant        quadrant 
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Graph 9: AUC for  Average Thickness  
 
 
 
 
 
 
 
 
0.
00
0.
25
0.
50
0.
75
1.
00
Se
n
sit
iv
ity
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.8674
57 
 
DISCUSSION 
 
The study was done to evaluate the  efficacy of spectral 
domain OCT in detecting  the glaucomatous ONH and RNFL 
changes in patients  with early to moderate glaucoma and 
compared  with their age matched controls. Optical coherence 
tomography works under the principle of  low-coherence 
interferometry to determine the echo time delay and magnitude of 
backscattered light reflected off an object of interest. which can be 
used to scan through the ocular structures with very high axial 
resolution (3 to 15 µm)  providing images demonstrating in 3 
dimension.Retinal nerve fibre layer (RNFL) thickness 
measurement  and ONH parameters  has become a widely used 
clinical tool for glaucoma assessment. Optical coherence 
tomography (OCT) is a technology providing RNFL thickness 
measurements  and ONH parameters in a non-contact and non-
invasive fashion. 
The visual field parameters analyzed in the study  were mean 
deviation and pattern standard deviation.The median of mean 
deviation  in the case group  was  -7.82 and  that of Pattern 
standard deviation was 5.565, which confirmed early to moderate 
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glaucoma in the case group .The absence of any glaucomatous 
changes in the control group were confirmed by their  visual field 
parameters . The  median in the control group for mean deviation 
was  -2.175 and that of Pattern Standard deviation was 2.47.  
Significant differences were found for the parameters in the two 
groups 
OCT can also be used to analyze optic nerve head (ONH) 
parameters, such as disc area, rim area, or cup-to-disc ratio, with 
good repeatability and reproducibility103,104 . The role of ONH 
parameters in early detection of glaucoma has been controversial in 
various studies , and this  feature has received less attention. In this 
study ONH parameters measured were CD Ratio, VCD Ratio, Rim 
area,Disc area,  and  Cup volume.  Significant differences were 
found between the ONH parameters in the control and case group . 
Several  other studies have shown  similar results, demonstrating 
that ONH analysis improves our ability to discriminate between 
healthy and glaucomatous eyes105-108 . 
 The   AUC represents, in a single number, the diagnostic 
accuracy of a test wherein a value of 1 represents perfect 
discrimination, while a value of 0.5 represents random 
discrimination. OCT parameters with AUC values above 0.80 are 
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generally considered to have good discriminating ability for a 
diagnostic test. Parameters with AUCs ranging from 0.70 to 0.80 
are only fair, and those with AUCs below 0.7 are considered poor. 
 
     In this study, all ONH parameters showed significant area 
under the curve (AUC) values in the ROC curve analysis . The best 
parameters detecting glaucomatous damage  from the optic nerve 
head analysis were the vertical Cup to Disc Ratio (AUC 0.98), the 
cup volume (0.83) and  the rim area  (AUC 0.82) , least AUC value  
was observed for the disc area  (AUC 0.65) . The  most reliable 
parameter for glaucoma detection was vertical cup to disc ratio in 
our study .This  parameter had  the greatest  sensitivity at 80 % 
specificity (98.31% ) followed by cup volume(78.81 %  ) .In 
glaucoma, the neuroretinal rim loss is initially seen at inferior pole  
followed by superior pole.This explains why the vertical cup to 
disc ratio is  a better diagnostic parameter  than the horizontal cup 
to disc ratio  in diagnosing pre-perimetric glaucoma  .A recent 
study by Medeiros et al.110 demonstrated that all ONH topographic 
parameters except for disc area were significantly different 
between normal individuals and those with glaucoma. In that study, 
the best individual parameter for glaucoma detection was found to 
be vertical cup-to-disc ratio (AUC = 0.83, sensitivity of 45% at a 
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specificity of 95%)  which is similar to our study .  Although disc 
area was found as poor indicator to detect glaucomatous damage in 
our study ,  study by Barbara C. Marsh et al    has quoted its 
importance in differentiatiang an glaucomatous cup from 
physiological large cup. An increase in OCT-determined rim area 
is to be expected with larger disc size as this parameter is directly 
derived from disc area and cup area. Comparative analysis of cup 
area and horizontal integrated rim width in relationship to overall 
disc size may prove useful in the clinical distinction of ONHs with 
physiologically large optic cups or optic discs with glaucomatous 
changes .111. Interestingly, in another study it was seen that  the 
vertical cup-to-disc diameter ratio corrected for disc size was one 
of the best variables123 . Hence  In our study , the reliability of the 
various parameters could have been best detected if it was adjusted 
for the disc area. 
RNFL thickness, in contrast to ONH parameters, is less 
controversial, and numerous reports have arrived at the consistent 
conclusion that it is a useful  marker for assessment of structural 
damage in glaucoma.112-115  
In our study statistically significant difference  in the mean 
average retinal thickness was seen in the case and control 
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group,indicating  glaucomatous process affecting the RNFL 
thickness .It was seen that in the control group ISNT rule of RNFL 
thickness was followed .Normal RNFL thickness values follow the 
ISNT rule with decreasing RNFL thickness values starting from the 
thickest quadrant inferiorly to the thinnest quadrant temporally . In 
the control group RNFL thickness  was  118.44 ± 14.89 in the 
inferior  , 116.78 ± 14.35 in superior  , 74.30 ± 13.91 in nasal  and  
71.54 ± 13.98 in temporal quadrant respectively. However  
considering the average RNFL thickness in the glaucomatous 
patient, it was seen that there was a violation of ISNT rule  in the 
case group ,the average thickness in inferior quadrant  was 90.69 ± 
23.9, 94.19 ± 17.96 in superior, 63.68 ± 14.81 in nasal , 60.66 ± 
12.91 in temporal quadrant.  Hence, ISNT rule for RNFL thickness 
can give a clue to Glaucomatous damage  .Though its statistical 
significance was not studied in this study , studies have 
demonstrated the usefulness of   The ISNT rule in differentiating 
normal from glaucomatous optic nerves  116,117 . 
In this study,  the parameter with the largest AUC among the 
RNFL parameters were the average RNFL thickness  (0.87) 
followed by superior(  0.84)   and  inferior (0.83) quandrants . The 
temporal ( 0.72)  and nasal  quadrants (0.69) had lower AUC 
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values as compared to the superior and inferior quadrants  . The 
parameter with the greatest  sensitivity at 80  % specificity were 
the average RNFL thickness (74% ) RNFL thickness in inferior 
quadrant (74% )  .  Hence, among the RNFL parameters, average 
RNFL thickness and inferior quadrant RNFL thickness  remained 
the best parameter with the highest AUC, followed closely by the 
superior quadrant average   . These OCT parameters had also been 
identified by previous study by Joseph Anthony  et al    as being 
the best for the diagnosis of glaucoma,  however they quoted other 
parameters like clock-hour sectors, the best were the 7 o’clock and 
11 o’clock sectors, followed closely by the 6 o’clock and 12 
o’clock sectors 109  , which was not studied in this study .    
   Studies by Sihota  et al identified the average thickness and 
the inferior quadrant as having the highest AUC.118   Medeiros 
credited the inferior quadrant with having the highest AUCs of 
0.92 in patients with early to moderate glaucoma  119 .  
In our study  too, we identified that among the RNFL 
parameters, both average RNFL thickness and inferior quadrant 
thickness  Average RNFL Thickness as having highest AUC, it 
was closely followed  by superior quadrants like other studies    
(superior( AUC = 0.84 , C.I =  0.79 – 0.89)   and  inferior (  AUC  
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=0.83 , C.I   =0.78 – 0.89    ) , the difference however were not 
statistically significant. 
As all the optic nerve fibers finally converge toward the 
ONH, one would expect a corresponding change in neuroretinal 
rim area/volume when there is reduction in RNFL thickness. Hence 
this study proves that besides the average RNFL thickness, the 
superior and inferior quadrant RNFL thickness were better 
indicators of the glaucomatous damage in early to moderate 
glaucoma  .This can be correlated  with the vertical cup to disc 
ratio acting as a better ONH parameter to detect  early 
glaucomatous damage than the horizontal Cup to disc ratio , as  the 
pattern of glaucomatous loss of neuroretinal rim  usually starts 
predominantly in the inferior and superior optic disc regions. AUC 
for  ONH  parameters   and  RNFL thickness in detecting 
glaucomatous changes is hence significant  .Similar results has 
been seen in study by Christopher Kai-shun Leung et al,  which 
reported both RNFL thickness and most of the ONH measurements 
attained similar performance in diagnostic sensitivity for glaucoma, 
however the performance of these two parameters in monitoring 
the progression of glaucoma was not evaluated in this study 120 .  
Demonstration of progressive optic disc changes requires 
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longitudinal follow-up and serial documentation of optic disc 
appearance. 
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LIMITATION 
The study was undertaken only on known cases  of glaucoma to 
evaluate the glaucomatous changes but the efficacy of these parameters in 
detecting the progression of these changes were not studied. The 
glaucoma suspects were not included in the study, hence the efficacy to 
predict future glaucomatous changes with these parameters is not known. 
The ONH parameters would have been better if they were corrected for 
disc area. The RNFL parameters were not studied for the clock hourwise 
distribution, hence focal glaucomatous changes could have been missed.  
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CONCLUSION 
 
In conclusion, SD OCT is an effective tool in evaluating the ONH 
and RNFL thickness to detect early to moderate glaucomatous changes. 
In the ONH parameters, the best predictor to detect these changes were 
Vertical cup to disc ratio.  The average RNFL thickness and the Superior 
and inferior RNFL  quadrant thickness are the most sensitive parameters 
to detect glaucomatous changes. Both the ONH and RNFL parameters are 
equally reliable as a diagnostic tool but their role in detecting the 
progression needs to be studied further with the long term study. The 
study also shows that as  age advances the RNFL thickness decreases and 
hence were comparable. 
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ABBREVIATIONS 
OCT              -     Optical Coherence Tomography  
SDOCT  - Spectral Domain Optical Coherence 
Tomography 
TDOCT  - Time Domain Optical Coherence Tomography 
RNFL  - Retinal nerve fiber layer 
ONH   - Optic nerve head 
POAG  - Primary open angle glaucoma 
PACG  - Primary angle closure glaucoma 
AUC   - Area Under the Receiver Operating 
Curve  
IOP   - Intraocular pressure 
RGCL  - Retinal ganglion cell layer 
NTG   - Normal tension glaucoma 
HTG   - High tension glaucoma 
PXEG  - Pseudoexfoliation glaucoma 
EMGT  - Early manifest glaucoma trial 
CNTGS  - Collabarative normal tension glaucoma study 
SLP   - Scanning laser polarimetry 
SLO   - Scanning laser ophthalmoscope 
NRA   - Neuroretinal rim area 
MD   - Mean deviation 
PSD   - Pattern standard deviation 
DB   - Decibel 
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PROFORMA 
Name     M.R.No.: 
Age 
Sex 
Diagnosis: RE 
         LE 
    OCULAR EXAMINATION 
BEST CORRECTED VISUAL ACUITY                         RE                      
LE 
Anterior segment: 
Lens      1.Clear 
               2.Cataract  
     3.Pseudoexfoliation 
     4.Subluxation/Dislocation 
 
Intraocular Pressure 
Time: 
 
FUNDUS 
Vertical cup to disc ratio 
Notching/Thinning of  Neuroretinal rim 
  1.Absent 
  2.Superior pole 
  3.Inferior pole 
Disc Haemorrhages 
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  1.Absent 
  2.Present 
Nerve Fiber Layer Defects 
  1.Absent 
  2.Inferior  
  3.Superior 
  4.Nasal 
  5.Temporal 
HFA 24-2 
Mean Deviation 
Pattern Standard Deviation 
 
CENTRAL CORNEAL THICKNESS 
 
 
 
 
 
 
 
 
 
ANALYSIS OF SD-OCT 
ONH PARAMETERS 
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ONH  PARAMETERS RE LE 
Cup to Disc ratio   
Vertical Cup to disc 
Ratio 
  
Disc Area   
Rim Area 
 
  
Cup Volume   
 
 
RNFL THICKNESS PARAMETERS 
   RNFL PARAMETERS
  
              RE             LE 
Average RNFL Thickness   
Inferior Quadrant   
Superior Quadrant   
Nasal Quadrant   
Temporal Quadrant   
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1 1380010 Dhanam,S 63 F POAG with PSEUDOPHAKIA POAG with PSEUDOPHAKIA 6/12P 6/12P 14mmhg 12mmhg Open Open -11.60dB -10.49dB 10.47dB 5.04dB 486µ 495µ 63µ 67µ 1.57 1.42 0.55 0.67 0.8 0.71 0.77 0.67 0.391 0.201 48µ 64µ 96µ 102µ 56µ 50µ 51µ 50µ
2 2068015 Dakshinamoorthi,S 58 M POAG POAG 6/6 6/9p 14mmhg 12mmhg Open Open -10.67dB -12.01dB 10.66dB 11.63dB 564µ 535µ 77µ 62µ 1.78 1.93 o.82 0.55 0.72 0.83 0.71 0.82 0.46 0.773 73µ 60µ 90µ 63µ 71µ 60µ 72µ 67µ
3 3271807 Veera Perumal,K 55 M POAG with PSEUDOPHAKIA POAG with PSEUDOPHAKIA 6/9 6/9 10mmg 10mmhg Open Open -8.18dB -9.12dB 12.12dB 8.19dB 486µ 437µ 72µ 93µ 3.11 2.87 1.1 1.22 0.79 0.75 0.78 0.69 0.998 0.892 82µ 125µ 92µ 110µ 45µ 79µ 69µ 57µ
4 3157282 Parthipan,G 49 M POAG POAG 6/12 6/12 20mmhg 20mmhg Open Open -2.13dB -4.08dB 1.60dB 2.08dB 551µ 551µ 105µ 71µ 2.49 2.79 1.18 0.77 0.71 0.84 0.62 0.8 0.503 1.008 146µ 100µ 125µ 75µ 73µ 49µ 74µ 61µ
5 3155647 Ajisha banu 41 F POAG POAG 6/6 6/6 22mhg 20mmhg Open Open -6.93dB -12.42dB 6.30dB 11.66dB 543µ 548µ 71µ 65µ 2.5 2.4 0.76 0.68 0.82 0.83 0.81 0.85 0.838 0.719 69µ 69µ 96µ 93µ 65µ 48µ 53µ 49µ
6 2738632 Ponnumanickam,P 67 M POAG with PSEUDOPHAKIA POAG with PSEUDOPHAKIA 6/6 6/6 18mmhg 18mmhg Open Open -10.98dB -9.12dB 5.42dB 6.42dB 434µ 456µ 75µ 78µ 3.06 3.08 1.21 1.26 0.77 0.75 0.73 0.73 0.577 0.519 104µ 98µ 91µ 98µ 42µ 67µ 61µ 47µ
7 1992869 Visalakshi,M 70 F POAG POAG 6/6 6/6 18mmhg 16mmhg Open Open -3.46dB -11.34dB 1.84dB 13.51dB 540µ 541µ 86µ 99µ 1.55 1.49 0.91 0.96 0.63 0.59 0.59 0.55 0.173 0.109 109µ 131µ 115µ 135µ 52µ 78µ 70µ 52µ
8 2924199 Gatha Devi,C.S 56 F POAG POAG 6/6 6/6 10mmhg 10mmhg Open Open -6.92dB -7.86dB 4.99dB 5.92dB 502µ 535µ 63µ 66µ 2.8 2.81 0.66 0.63 0.86 0.87 0.85 0.85 0.433 0.288 64µ 69µ 85µ 81µ 45µ 67µ 60µ 48µ
9 1895140 Arumugam,R 50 M POAG POAG 6/6 6/6 14mmhg 18mmhg Open Open -5.91dB -4.03dB 3.99dB 1.40dB 529µ 535µ 67µ 73µ 2.46 2.12 0.67 0.89 0.75 0.7 0.77 0.76 0.565 0.655 57µ 106µ 104µ 112µ 43µ 69µ 70µ 71µ
10 3268716 Vijaraghavan,M 60 M POAG POAG 6/6 6/6 16mmhg 19mmhg Open Open -5.23dB -12.35dB 7.47dB 8.14dB 486µ 486µ 76µ 75µ 2.56 1.86 0.78 0.98 0.67 0.71 0.65 0.7 0.455 0.433 105µ 65µ 95µ 79µ 35µ 60µ 62µ 33µ
11 3269526 Muthukamatchi,G 50 M POAG POAG 6/6 6/6 16mmhg 16mmhg Open Open -9.81dB -11.09dB 7.25dB 8.24dB 546µ 532µ 99µ 80µ 3.03 2.31 0.68 0.61 0.87 0.84 0.83 0.78 0.435 0.525 102µ 87µ 101µ 94µ 106µ 59µ 86µ 81µ
12 3269891 Ruby Varghese 39 F POAG POAG 6/6 6/6 12mmhg 12mmhg Open Open -6.54dB -7.12dB 4.65dB 5.16dB 512µ 514µ 76µ 84µ 2.32 2.19 0.96 1.08 0.76 0.7 0.73 0.68 0.57 0.432 120µ 113µ 65µ 100µ 55µ 62µ 64µ 62µ
13 3270172 Ponnammal,S 51 F POAG POAG 6/6 6/6 12mmhg 12mmhg Open Open -7.78dB -8.56dB 6.71dB 5.78dB 435µ 435µ 80µ 81µ 1.92 1.88 0.92 0.77 0.71 0.76 0.67 0.72 0.271 0.406 90µ 87µ 94µ 115µ 61µ 68µ 73µ 55µ
14 2162451 Abdul Raseek,A 46 M POAG POAG 6/6p 6/6p 11mmhg 12mmhg Open Open -0.36dB -6.85dB 1.98dB 7.64dB 519µ 519µ 88µ 82µ 1.88 1.36 0.82 0.89 0.6 0.65 0.62 0.66 0.546 0.569 104µ 73µ 116µ 68µ 73µ 63µ 58µ 58µ
15 3158022 Janaki,P 60 F POAG POAG 6/12 6/9 22mmhg 16mmhg Open Open -10.04dB -5.49dB 2.08dB 2.73dB 535µ 535µ 79µ 82µ 1.46 1.59 1.19 0.98 0.65 0.71 0.68 0.7 0.455 0.521 68µ 100µ 89µ 103µ 46µ 59µ 61µ 55µ
16 3183447 Purushothaman,K 59 M POAG POAG 6/6 6/6p 16mmhg 16mmhg Open Open -11.09dB -9.12dB 5.65db 6.37dB 465µ 457µ 81µ 80µ 1.62 1.58 1.12 1.38 0.78 0.81 0.75 0.76 0.657 0.486 127µ 118µ 121µ 80µ 75µ 89µ 98µ 68µ
17 3157278 Jayalakshmi,P 56 F POAG POAG 6/6p 6/9 14mmhg 14mmhg Open Open -9.92dB -11.52dB 5.09dB 5.57dB 576µ 551µ 78µ 79µ 1.56 1.61 0.98 0.88 0.77 0.71 0.75 0.7 0.569 0.325 98µ 92µ 101µ 93µ 92µ 84µ 84µ 84µ
18 3178396 Muthuchelliah,K 47 M POAG POAG 6/6 6/6 16mmhg 16mmhg Open Open -2.16dB -5.35dB 2.31dB 5.34dB 584µ 580µ 90µ 89µ 1.82 1.73 1.32 1.12 0.78 0.81 0.75 0.8 0.65 0.548 84µ 71µ 86µ 96µ 73µ 97µ 86µ 79µ
19 2653269 Jeyachandran,S 70 M POAG POAG 6/12 6/12 25mmhg 27mmhg Open Open -7.99dB -4.46dB 2.93dB 2.32dB 502µ 502µ 78µ 81µ 1.53 1.46 1.13 0.99 0.81 0.85 0.8 0.86 0.465 0.569 87µ 72µ 87µ 89µ 62µ 63µ 67µ 61µ
20 3073162 Santhamma,J 60 F POAG POAG 6/6 6/6 12mmhg 12mmhg Open Open -12.56dB -6.62dB 10.16dB 2.66dB 519µ 563µ 73µ 71µ 1.32 1.56 0.98 1.03 0.85 0.78 0.83 0.79 0.566 0.489 118µ 122µ 99µ 102µ 64µ 68µ 57µ 62µ
21 2161141 Karthikeyan,P 30 M POAG POAG 6/9 6/9 15mmhg 18mmhg Open Open -8.71dB -11.30dB 4.8dB 4.01dB 502µ 502µ 89µ 91µ 1.56 1.78 1.18 0.91 0.78 0.69 0.77 0.7 0.547 0.431 74µ 78µ 85µ 87µ 63µ 58µ 75µ 82µ
22 2328614 Noorjahan,A 67 F POAG POAG 6/6 6/6 12mmhg 13mmhg Open Open -11.10dB -11.92dB 5.21dB 3.74dB 513µ 502µ 92µ 87µ 1.45 1.56 1.12 1.03 0.7 0.65 0.72 0.65 0.43 0.564 85µ 107µ 90µ 120µ 94µ 94µ 70µ 68µ
23 2897235 Srinivasan,V 34 M POAG POAG 6/6 6/6 17mmhg 20mmhg Open Open -11.00dB -9.15dB 14.48dB 13.91dB 535µ 519µ 66µ 72µ 2.03 1.89 0.68 0.77 0.8 0.76 0.81 0.77 0.666 0.482 71µ 51µ 81µ 113µ 55µ 56µ 57µ 70µ
24 2708488 Nishanth,P.S 23 M POAG POAG 6/6 6/6 18mmhg 11mmhg Open Open -2.27dB -1.76dB 3.16dB 2.56dB 555µ 534µ 72µ 85µ 2.03 2.58 0.77 0.93 0.77 0.79 0.75 0.73 0.674 0.916 101µ 104µ 67µ 111µ 56µ 59µ 64µ 64µ
25 3215328 Jeeva Regha 61 F POAG POAG 6/9 6/9 11mmhg 16mmhg Open Open -10.56dB -8.98dB 8.18dB 9.12dB 489µ 465µ 89µ 78µ 2.61 1.98 1.32 1.42 0.8 0.71 0.8 0.75 0.544 0.788 56µ 100µ 104µ 117µ 86µ 98µ 64µ 58µ
26 3207041 Bhaskaran Pillai,V 72 M POAG POAG 6/9 6/6p 34mmhg 16mmhg Open Open -12.14dB -8.58dB 7.07dB 9.04dB 544µ 544µ 62µ 92µ 2.03 2.41 0.90 1.41 0.73 0.63 0.71 0.6 0.264 0.193 71µ 109µ 72µ 131µ 52µ 72µ 52µ 57µ
27 3172777 Mohammed Ibrahim,M 64 M POAG POAG 6/6 6/6 20mmhg 22mmhg Open Open -11.56dB 9.10dB 9.16dB 9.89dB 518µ 535µ 84µ 77µ 2.35 1.98 1.19 0.8 0.69 0.76 0.63 0.68 0.33 0.438 117µ 93µ 93µ 100µ 78µ 65µ 49µ 48µ
28 3293749 Sadiq Ali 42 M POAG POAG 6/6 6/6 20mmhg 20mmhg Open Open -9.53dB -10.70dB 9.88dB 10.42dB 589µ 584µ 78µ 81µ 1.78 1.81 1.1 1.03 0.71 0.65 0.75 0.68 0.455 0.352 113µ 129µ 118µ 134µ 61µ 81µ 82µ 65µ
29 3296749 Sithima,A 68 F POAG POAG 6/6 6/6 16mmhg 16mmhg Open Open -1.50dB -1.86dB 2.47dB 2.202dB 568µ 568µ 88µ 72µ 1.92 3.99 0.95 1.31 0.7 0.71 0.67 0.69 0.143 0.635 122µ 69µ 89µ 106µ 74µ 56µ 67µ 58µ
30 2506925 Rajeshwari,J 49 F POAG POAG 6/6 6/6 12mmhg 14mmhg Open Open 11.31dB -8.71dB 13.69dB 9.57dB 515µ 510µ 83µ 76µ 1.82 1.78 1.21 0.89 0.81 0.76 0.8 0.77 0.655 0.534 59µ 65µ 112µ 110µ 57µ 63µ 67µ 65µ
31 1888389 Veera kumar,A.V 46 M POAG POAG 6/6 6/9 12mmhg 16mmhg Open Open -8.33dB -12.68dB 6.29dB 12.30dB 502µ 486µ 85µ 73µ 1.67 1.71 1.03 1.01 0.78 0.69 0.71 0.76 0.452 0.231 101µ 99µ 79µ 87µ 76µ 81µ 56µ 54µ
32 2195382 Marimuthu,R 65 M POAG POAG 6/6 6/6 12mmhg 12mmhg Open Open -2.86dB -11.67dB 2.99dB 13.26dB 512µ 514µ 68µ 59µ 1.77 1.66 0.67 1.22 0.78 0.48 0.78 0.43 0.533 0.388 67µ 53µ 96µ 84µ 55µ 55µ 53µ 43µ
33 3345595 Prasath,C 34 M POAG POAG 6/12 6/9 28mmhg 22mmhg Open Open -12.28dB -3.48dB 5.46dB 2.29dB 502µ 502µ 57µ 88µ 2.37 2.56 0.3 1.24 0.92 0.71 0.91 0.67 1.339 0.485 58µ 104µ 52µ 123µ 59µ 69µ 57µ 56µ
34 3337747 Ravi,V 46 M POAG POAG 6/6 6/6 16mmhg 18mmhg Open Open -3.07dB -11.36dB 2.81dB 14.13dB 584µ 584µ 75µ 77µ 2.13 1.98 0.98 1.03 0.7 0.73 0.76 0.75 0.467 0.512 136µ 57µ 102µ 84µ 56µ 73µ 93µ 55µ
35 3335082 Rajagopalan,P.N 69 M POAG POAG 6/6 6/6 24mmhg 21mmhg Open Open -3.37dB -3.81dB 3.98dB 5.67dB 546µ 551µ 65µ 64µ 2.08 1.98 0.66 0.65 0.81 0.81 0.83 0.71 0.787 0.603 68µ 56µ 85µ 92µ 33µ 68µ 75µ 42µ
36 3334891 Thiruselvam,S 47 M POAG POAG 6/6 6/6 26mmhg 28mmhg Open Open -4.26dB -5.30dB 3.46dB 2.83dB 519µ 519µ 77µ 80µ 2.27 2.02 1.07 0.88 0.71 0.74 0.68 0.7 0.408 0.511 108µ 103µ 99µ 115µ 40µ 60µ 61µ 42µ
37 3333373 Gomathi,P 45 F POAG POAG 6/12 6/6 30mmhg 28mmhg Open Open -7.18dB -8.18dB 5.56dB 6.12dB 584µ 568µ 62µ 83µ 2.02 2.21 0.93 0.9 0.72 0.75 0.71 0.68 0.292 0.507 54µ 113µ 78µ 96µ 49µ 73µ 68µ 50µ
38 3332861 Amsavalli,R 40 F POAG POAG 6/6 6/6 24mmhg 20mmhg Open Open -9.56dB -9.67dB 11.72dB 12.45dB 470µ 470µ 85µ 78µ 1.99 1.9 1.01 0.89 0.69 0.72 0.64 0.68 0.427 0.386 98µ 100µ 87µ 76µ 67µ 68µ 54µ 42µ
39 2010759 Ajoykumar,P 61 M POAG POAG 6/6 6/9 18mmhg 18mmhg Open Open -11.35dB -3.61dB 1.08dB 2.32dB 552µ 556µ 82µ 73µ 1.98 1.66 0.87 0.73 0.73 0.77 0.67 0.75 0.423 0.408 100µ 74µ 117µ 112µ 53µ 60µ 59µ 48µ
40 2311199 Mohammed Zafarullah,N 60 M POAG POAG 6/6 6/6 22mmhg 25mmhg Open Open -1.62dB 2.19dB 3.32dB 2.80dB 551µ 535µ 55µ 56µ 1.81 1.81 0.58 0.61 0.81 0.8 0.81 0.78 0.609 0.499 97µ 101µ 89µ 92µ 76µ 78µ 54µ 62µ
41 2262272 Varadarajan,R 70 M POAG POAG 6/6 6/6 14mmhg 12mmhg Open Open -1.50dB 3.43dB 3.42dB 3.27dB 435µ 435µ 103µ 91µ 2.18 2.33 0.97 0.93 0.73 0.77 0.66 0.74 0.604 0.726 89µ 92µ 99µ 89µ 74µ 76µ 67µ 52µ
42 3339540 Balasubramaniam,M.B 62 M POAG POAG 6/9 6/9 18mmhg 12mmhg Open Open -2.65dB -6.48dB 9.90dB 7.89dB 519µ 535µ 80µ 76µ 1.67 1.98 0.74 0.88 0.75 0.76 0.73 0.77 0.543 0.486 62µ 54µ 47µ 64µ 39µ 68µ 52µ 50µ
43 3340105 Ananthachari 72 M POAG POAG 6/12 6/9 22mmhg 18mmhg Open Open -8.64dB -7.12dB 7.78dB 5.62dB 565µ 556µ 70µ 71µ 1.38 1.35 0.24 0.15 0.79 0.92 0.88 0.92 0.147 0.441 82µ 81µ 61µ 70µ 78µ 24µ 59µ 110µ
44 3340904 Jayachandran,G 61 M POAG POAG 6/6 6/9 28mmhg 26mmhg Open Open -4.57dB -4.57dB 2.86dB 3.41dB 486µ 453µ 65µ 54µ 2.02 1.9 0.74 0.23 0.78 0.92 0.85 0.91 0.658 0.933 96µ 50µ 54µ 58µ 54µ 49µ 59µ 60µ
45 3318944 Raju,T 55 M POAG POAG 6/6 6/6 18mmhg 18mmhg Open Open -6.67dB -5.98d 4.12dB 6.89dB 512µ 513µ 77µ 77µ 2.46 2.55 0.79 0.93 0.81 0.79 0.78 0.75 1.004 0.639 83µ 100µ 102µ 97µ 56µ 54µ 65µ 59µ
46 3233294 Saroja,N.K 60 F POAG POAG 6/6p 6/6p 18mmhg 19mmhg Open Open -8.18dB -5.16dB 7.05dB 2.51dB 502µ 503µ 58µ 68µ 1.8 1.61 0.5 0.74 0.83 0.73 0.81 0.61 0.552 0.34 50µ 78µ 92µ 92µ 47µ 50µ 43µ 50µ
47 1620838 Subramanian,R 75 M POAG POAG 6/6 6/6 16mmhg 14mmhg Open Open -7.44dB -1.24dB 6.69dB 1.46dB 534µ 542µ 67µ 86µ 2.06 2.13 0.64 0.97 0.81 0.73 0.8 0.63 0.864 0.377 74µ 100µ 71µ 109µ 60µ 70µ 64µ 63µ
48 2155179 Annapandiyan,R 50 M POAG POAG 6/6 6/6 22mmhg 16mmhg Open Open -11.42dB -4.94dB 1.31dB 1.66dB 519µ 509µ 90µ 79µ 1.93 1.7 0.84 0.83 0.74 0.7 0.72 0.69 0.601 0.385 103µ 84µ 99µ 106µ 77µ 67µ 79µ 61µ
49 2690511 Rathinam,D 50 M POAG POAG 6/6 6/6 18mmhg 18mmhg Open Open -8.42dB -7.62dB 5.62dB 3.42dB 519µ 519µ 91µ 81µ 1.89 1.78 0.98 0.88 0.75 0.66 0.73 0.67 0.6 0.533 94µ 126µ 91µ 112µ 53µ 63µ 69µ 57µ
50 3295378 Senthilkumar,K.M 41 M POAG POAG 6/6 6/6 18mmhg 18mmhg Open Open -8.19dB -6.22dB 5.32dB 1.89dB 486µ 482µ 76µ 75µ 2.98 2.46 0.89 0.73 0.81 0.78 0.8 0.79 0.601 0.733 121µ 114µ 99µ 103µ 54µ 60µ 64µ 49µ
51 3309221 Raja,P 41 M POAG POAG 6/6 6/6 18mmhg 17mmhg Open Open -7.02dB -3.98dB 3.37dB 2.36dB 495µ 490µ 78µ 73µ 3.28 3.41 0.65 0.72 0.88 0.88 0.89 0.88 1.944 1.859 94µ 81µ 91µ 96µ 62µ 59µ 66µ 54µ
52 3310145 Nagarajan,S 62 M POAG POAG 6/6 6/9 24mmhg 24mmhg Open Open -4.99dB -11.06dB 5.49dB 8.46dB 568µ 553µ 65µ 61µ 1.92 2.45 0.78 0.99 0.76 0.76 0.78 0.81 0.444 0.682 90µ 112µ 98µ 89µ 67µ 65µ 54µ 49µ
53 3315173 Lakshmi,S 52 F POAG POAg 6/6 6/6 18mmhg 18mmhg Open Open -10.19dB -9.81dB 9.68db 6.42dB 455µ 465µ 81µ 78µ 2.82 2.47 1.07 0.96 0.78 0.77 0.74 0.73 0.584 0.538 107µ 101µ 106µ 109µ 43µ 58µ 66µ 43µ
54 2715019 Velmurugan,P 38 M POAG POAG 6/6 6/6 17mmhg 17mmhg Open Open -4.56dB -4.32dB 4.56dB 5.62dB 498µ 479µ 96µ 93µ 1.75 1.81 1.09 1.03 0.61 0.64 0.58 0.64 0.274 0.294 108µ 99µ 111µ 89µ 78µ 65µ 54µ 56µ
55 2598747 Fathimuthu,M 60 F POAG POAG 6/6 6/6 13mmhg 12mmhg Open Open -11.51dB -10.93dB 5.92dB 4.97dB 519µ 532µ 58µ 67µ 2.66 2.55 0.67 0.85 0.85 0.8 0.79 0.77 0.974 0.853 85µ 88µ 67µ 85µ 29µ 58µ 50µ 37µ
56 3319414 Haiyar nisha,Dr 62 F POAG POAG 6/6 6/6 24mmhg 22mmhg Open Open -12.25dB -10.30dB 4.49dB 8.61dB 535µ 535µ 56µ 55µ 2.21 2.14 0.48 0.85 0.87 0.76 0.91 0.75 0.595 0.341 58µ 54µ 64µ 68µ 46µ 48µ 57µ 48µ
57 3308326 Velusamy.N 33 M POAG POAG 6/6 6/6 21mmhg 23mmhg Open Open -14.66dB -6.60dB 9.85dB 7.75dB 486µ 486µ 56µ 64µ 1.28 1.27 0.32 0.61 0.85 0.71 0.82 0.73 0.576 0.321 60µ 73µ 61µ 84µ 57µ 55µ 44µ 46µ
58 3290601 Nagamma,V 60 F POAG POAG 6/6 6/6 16mmhg 16mmhg Open Open -4.97dB -6.20dB 1.90dB 2.50dB 486µ 486µ 96µ 78µ 2.16 2.62 0.92 0.79 0.74 0.82 0.68 0.78 0.648 0.907 113µ 94µ 125µ 114µ 77µ 80µ 71µ 24µ
59 2531540 Avudai Nayagam 60 M POAG POAG 6/6 6/6 18mmhg 18mmhg Open Open -5.57dB -5.30dB 6.33dB 7.55dB 502µ 503µ 96µ 90µ 2.1 2.29 0.97 1.03 0.72 0.73 0.68 0.69 0.375 0.309 128µ 125µ 97µ 102µ 93µ 77µ 65µ 58µ
Diagnosis
B
C
V
A
I
O
P
G
o
n
i
o
s
c
o
p
y
V
e
r
t
i
c
a
l
 
C
/
D
 
R
a
t
i
o
P
a
t
t
e
r
n
 
M
e
a
n
 
S
D
C
C
T
M
e
a
n
 
A
v
e
r
a
g
e
 
T
h
i
c
k
n
e
s
s
D
i
s
c
 
A
r
e
a
 
(
m
m
 
)
2
 
R
i
m
 
A
r
e
a
 
(
m
m
 
)
2
 
C
/
D
 
R
a
t
i
o
I
n
f
e
r
i
o
r
 
 
Q
u
a
d
r
a
n
t
S
u
p
e
r
i
o
r
 
Q
u
a
d
r
a
n
t
 
N
a
s
a
l
 
Q
u
a
d
r
a
n
t
T
e
m
p
o
r
a
l
 
Q
u
a
d
r
a
n
t
M
e
a
n
 
D
e
v
i
a
t
i
o
n
C
u
p
 
V
o
l
u
m
e
 
(
m
m
 
)
3
